Patients Ending the silence: Why the menopause matters in the workpla... One of the biggest challenges for women in their 40s and 50s going through the menopause is the recognition that one size does not fit all.
Oncology Treating primary bone cancer: The potential of listeria-base... In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face